Questions
Kisspeptin FAQ
Direct, cited answers to the questions people actually ask about kisspeptin.
What is kisspeptin?
Kisspeptin is the KISS1 gene product and a KISS1R/GPR54 agonist — a reproductive neuropeptide that is the principal upstream activator of GnRH neurons. Loss-of-function GPR54 mutations cause failure of puberty in humans, and Gpr54-knockout mice reproduce that phenotype, establishing the signal as essential for reproductive maturation [1]. It acts one rung above the sex hormones, not as a hormone itself.
What is kisspeptin used for in research?
In supervised research, kisspeptin is studied to trigger oocyte maturation in IVF without causing OHSS [5], to restore LH pulses in women with hypothalamic amenorrhea [4], and to probe sexual-desire brain circuits. A systematic review identified 29 interventional trials across amenorrhea, puberty, ovarian function, and fertility regulation [7]. No use is regulatory-approved; all of it is investigational.
What receptor does kisspeptin bind?
Kisspeptin binds KISS1R, formerly called GPR54 — a Gq/11-coupled G-protein-coupled receptor on hypothalamic GnRH neurons. Loss-of-function mutations in this receptor cause hypogonadotropic hypogonadism and failure of puberty [1], and kisspeptin fails to stimulate LH or FSH in Gpr54-knockout mice, confirming the receptor as the obligatory control point [13].
How does kisspeptin work in the body?
Kisspeptin docks on KISS1R on GnRH neurons, triggering a phospholipase C / IP3 / calcium cascade that depolarizes the neuron and drives pulsatile GnRH release [2]. GnRH then stimulates pituitary LH and FSH secretion, which drives the gonads to make sex steroids. It is the upstream switch of the hypothalamic-pituitary-gonadal axis — it does not supply any hormone directly.
What is the mechanism by which kisspeptin-10 exerts its effects?
Kisspeptin-10 binds KISS1R and excites GnRH neurons through the same Gq/11 / PLC / IP3 / calcium pathway that closes potassium channels and opens cation channels, depolarizing the cell [2]. In healthy men, an intravenous KP-10 bolus drove LH from 4.1 to 12.4 IU/L within 30 minutes [3]. Its effect is short because plasma peptidases clear KP-10 within minutes.
What are KNDy neurons and how do they relate to kisspeptin?
KNDy neurons are arcuate-nucleus neurons that co-express Kisspeptin, Neurokinin B, and Dynorphin, and they are thought to act as the GnRH pulse generator. In ewes, neurokinin B signaling initiates synchronized activity, dynorphin terminates each burst, and kisspeptin relays the output to GnRH neurons [8]. This model is regarded as the mammalian pulse generator controlling reproduction [9].
What does kisspeptin do?
Kisspeptin starts the reproductive cascade: it fires GnRH neurons, which trigger pituitary LH and FSH, which drive the gonads to make sex steroids. It was discovered because losing its receptor blocks puberty entirely [1]. In studies it raises LH, FSH, and testosterone in men [16], restores cycles in hypothalamic amenorrhea [4], and triggers ovulation in IVF [5].
Does kisspeptin increase testosterone?
Yes, indirectly, in studied populations. In healthy men, a continuous intravenous kisspeptin-10 infusion at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L by stimulating LH, which signals the testes to produce testosterone [3]. Kisspeptin does not supply testosterone itself; it acts upstream on the GnRH neurons that ultimately drive its production.
How much does kisspeptin increase testosterone?
In one healthy-men study, continuous intravenous kisspeptin-10 at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L, alongside a rise in LH and LH pulse frequency [3]. This is a single research finding at a stated dose and route in healthy men, not a general or reproducible human-use figure, and it is not a dosing recommendation.
Can kisspeptin help with fertility?
In research, yes — as an IVF trigger. In a Phase 2 trial of 60 women at high OHSS risk, a single subcutaneous kisspeptin-54 dose (3.2-12.8 nmol/kg) matured oocytes in 95% of women with no case of moderate, severe, or critical OHSS, and the highest live-birth rate (62%) followed the 9.6 nmol/kg dose [5]. It remains investigational and unapproved for fertility use.
Can kisspeptin restore ovulation in women with hypothalamic amenorrhea?
In supervised research it restored LH pulsatility, a prerequisite for ovulation. Continuous intravenous kisspeptin-54 (0.01-1.00 nmol/kg/h) raised LH pulses from 1.6 to 5.0 per 8 hours (~3-fold) and pulse secretory mass about 6-fold versus vehicle in women with hypothalamic amenorrhea [4]. The highest dose, however, produced tachyphylaxis over the infusion. It is investigational, not an approved treatment.
What is the difference between kisspeptin-10 and kisspeptin-54?
Both are isoforms of the same molecule sharing the receptor-binding RF-amide tail, but they differ in length and duration. Kisspeptin-54 (KP-54, originally metastin) is the 54-residue form with a human half-life of about 27-28 minutes; kisspeptin-10 (KP-10) is the short decapeptide cleared within roughly 4 minutes [3]. KP-54 carries most multi-hour clinical applications; KP-10 suits short pharmacological challenges.
What is the KISS1 gene?
KISS1 is the gene on chromosome 1q32 that encodes the kisspeptin precursor, which is cleaved into kisspeptin-54 and shorter fragments. It was first identified in 1996 as a metastasis-suppressor gene in melanoma before its reproductive role was known. Loss-of-function mutations in its receptor (GPR54/KISS1R) cause failure of puberty, defining KISS1 signaling as essential for reproduction [1].
What is metastin and how does it relate to kisspeptin?
Metastin is the original name for kisspeptin-54, given when KISS1 was identified as a metastasis-suppressor gene. The terms are used interchangeably: metastin and kisspeptin-54 (KP-54) refer to the same 54-amino-acid isoform. The name reflects the gene's first-discovered role in suppressing tumor spread, which preceded the discovery that the peptide is the master switch of the reproductive axis [1].
How was kisspeptin discovered?
KISS1 was discovered in 1996 as a metastasis-suppressor gene in human melanoma and named for Hershey, Pennsylvania. Its orphan receptor GPR54 was deorphanized around 2001, and in 2003 two groups independently showed that loss-of-function GPR54 mutations cause hypogonadotropic hypogonadism and failure of puberty — reframing kisspeptin as the master upstream switch of the reproductive axis [1].
How long does kisspeptin take to work?
Quickly, on the hormone readouts. In healthy men, an intravenous kisspeptin-10 bolus drove LH from 4.1 to 12.4 IU/L within 30 minutes [3], and in the 2025 intranasal study LH rose rapidly after dosing [6]. These are acute hormonal responses measured in minutes to an hour; they are research findings, not a guide to any personal effect or timeline.
What is the half-life of kisspeptin?
It depends on the isoform. Kisspeptin-10 has a functional half-life of about 4 minutes in humans, cleared rapidly by plasma peptidases; kisspeptin-54 lasts much longer, about 27-28 minutes (27.6 +/- 1.1 minutes reported in early work), because its larger size resists endopeptidase cleavage [3]. That gap explains why KP-54 carries the longer clinical applications.
How does stress suppress kisspeptin and disrupt the reproductive axis?
Hypothalamic amenorrhea — loss of periods from low body weight, heavy exercise, or stress — is associated with reduced kisspeptin-neuron activity and suppressed GnRH pulsatility. In affected women, supplying kisspeptin-54 restored LH pulses roughly threefold versus vehicle, indicating the axis was quietened upstream rather than broken [4]. This positions reduced kisspeptin signaling as a plausible link between stress and a stalled reproductive axis.
How does kisspeptin reduce OHSS risk compared to hCG as an IVF trigger?
Conventional IVF triggers can over-stimulate the ovaries and cause OHSS, a potentially serious complication. Kisspeptin-54 instead triggers the body's own short-lived LH surge through the natural GnRH pathway: in 60 high-risk women, a single subcutaneous dose matured oocytes in 95% with no case of moderate, severe, or critical OHSS [5]. The self-limiting surge is the proposed safety advantage.
Can kisspeptin-54 trigger ovulation more safely than GnRH agonists in IVF?
In research, kisspeptin-54 triggered oocyte maturation in 95% of high-OHSS-risk women with zero cases of moderate-to-critical OHSS and a 62% live-birth rate at the 9.6 nmol/kg dose [5]. By acting upstream to evoke a physiological LH surge, it is being studied as a gentler trigger, but it remains investigational and is not an approved alternative to any standard trigger.
Does kisspeptin help with hypothalamic amenorrhea?
In supervised studies it restored the missing hormonal pulses. Continuous intravenous kisspeptin-54 raised LH pulses from 1.6 to 5.0 per 8 hours and pulse secretory mass about 6-fold versus vehicle in women with hypothalamic amenorrhea [4]. High doses produced tachyphylaxis, so spacing matters. It is an investigational research finding, not an approved treatment for the condition.
Why does kisspeptin-54 produce longer-lasting LH release than kisspeptin-10?
Kisspeptin-54 is larger and more resistant to the endopeptidases that rapidly cleave kisspeptin-10, giving it a human half-life of about 27-28 minutes versus roughly 4 minutes for KP-10 [3]. The longer circulating presence sustains receptor engagement and so a longer LH response. In the 2025 intranasal study, KP-54 stimulated LH across all three groups tested [6].